![](/images/Email.png)
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
SignalRx Pharmaceuticals, Inc.
US Patent
SignalRx Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 6.30E+3nMAssay Description:Several TP Scaffold compounds were tested for inhibition activity against isoforms of PI3K (alpha, beta, gamma, and delta isoforms) and the bromodoma...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
SignalRx Pharmaceuticals, Inc.
US Patent
SignalRx Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 6.30E+3nMAssay Description:Inhibitory activity can be determined routinely using known methods and also from commercial vendors offering this service for kinases and bromodomai...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
SignalRx Pharmaceuticals, Inc.
US Patent
SignalRx Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 6.30E+3nMAssay Description:Inhibition of PI3K p110gamma (unknown origin)More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)